Trials / Withdrawn
WithdrawnNCT01067677
Rescue Emetic Therapy for Children Having Elective Surgery
Rescue Emetic Therapy for Children Having Elective Therapy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Franklyn Cladis · Academic / Other
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
To compare ondansetron, metoclopramide, diphenhydramine, and placebo in order to determine which anti-emetic is most efficacious as a "rescue therapy" for pediatric patients ages 3-18 who have post-operative vomiting after a standardized prophylactic regimen of ondansetron and dexamethasone. We hypothesize that anti-emetics with a different mechanism of action than the prophylactic regimen will be the most effective "rescue therapy" in children having surgery in an ambulatory surgery center. 1. Problem: Despite commonly-used anti-emetics for prophylaxis, some children still go on to develop post-operative vomiting (POV). Goal: To determine which anti-emetic--ondansetron, metoclopramide, diphenhydramine, or placebo--is most efficacious for pediatric patients in this situation. 2. Hypothesis: Anti-emetic medications that have a different mechanism of action than the prophylactic regimen will be the most efficacious "rescue therapy." 3. Hypothesis: Metoclopramide at the dose of 0.5 mg/kg (max dose 20 mg) will be more effective than ondansetron, diphenhydramine, or placebo as "rescue therapy."
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metaclopramide | 0.5 mg/kg for rescue after PONV |
| DRUG | Ondansetron | 0.1 mg/kg (max 4 mg0 |
| DRUG | diphenhydramine | 0.25 mg/kg (max 25 mg) |
| DRUG | Saline | equal volume (5 ml)as experimental rescue medications |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2012-02-01
- Completion
- 2014-02-01
- First posted
- 2010-02-11
- Last updated
- 2017-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01067677. Inclusion in this directory is not an endorsement.